German Pharmaceuticals & Biotech Potentially Undervalued Companies

Spectrum Pharmaceuticals

Market Cap: €209.9m

Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology drug products.

Indivior Pharmaceuticals

Market Cap: €4.6b

Engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.

Grand Pharmaceutical Group

Market Cap: €18.3b

An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.

Green Thumb Industries

Market Cap: €2.1b

Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.

UCB

Market Cap: €42.5b

A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.

Perrigo

Market Cap: €1.8b

Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

Prestige Consumer Healthcare

Market Cap: €2.6b

Develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.

Trajan Group Holdings

Market Cap: €29.8m

Develops, manufactures, and sells analytical and life science products and devices in Malaysia, Japan, Australia, New Zealand, the United States, Europe, the Middle East, Africa, and India.

Bavarian Nordic

Market Cap: €13.5b

Develops, manufactures, and supplies life-saving vaccines.

UCB

Market Cap: €42.5b

A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.

United Laboratories International Holdings

Market Cap: €18.2b

An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.

United Therapeutics

Market Cap: €23.1b

Engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.

Bausch Health Companies

Market Cap: €2.3b

Operates as a diversified specialty pharmaceutical and medical device company.

China Resources Pharmaceutical Group

Market Cap: €30.4b

An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.

Cresco Labs

Market Cap: €463.2m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.

China Medical System Holdings

Market Cap: €30.0b

An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.

Consun Pharmaceutical Group

Market Cap: €11.8b

Produces and sells pharmaceutical products in Mainland China.

CorMedix

Market Cap: €583.7m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

Laboratorios Farmaceuticos Rovi

Market Cap: €3.0b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.

Dermapharm Holding

Market Cap: €2.0b

Manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China.

TG Therapeutics

Market Cap: €7.1b

A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.

High Tide

Market Cap: €282.1m

Engages in the cannabis retail business in Canada, the United States, and internationally.

Vetoquinol

Market Cap: €843.8m

A veterinary pharmaceutical company, engages in designing, developing, and selling of veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region.

Dermapharm Holding

Market Cap: €2.0b

Manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China.

Shionogi

Market Cap: €2.4t

Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.

Santen Pharmaceutical

Market Cap: €620.9b

Engages in the research and development, production, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.

Bavarian Nordic

Market Cap: €13.5b

Develops, manufactures, and supplies life-saving vaccines.

Goodbody Health

Market Cap: €1.3m

Goodbody Health Inc., a wellness company, provides health and wellness range of products and services in the United Kingdom.

Hikma Pharmaceuticals

Market Cap: €3.3b

Develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products.

Fortrea Holdings

Market Cap: €1.7b

A contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.

Viatris

Market Cap: €18.9b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Bayer

Market Cap: €48.9b

Operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.

ACADIA Pharmaceuticals

Market Cap: €4.9b

A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.

GSK

Market Cap: €78.6b

Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

TerrAscend

Market Cap: €266.7m

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.

Gossamer Bio

Market Cap: €87.0m

A clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary hypertension and pulmonary arterial hypertension in the United States.